Eli Lilly’s once-daily oral pill orforglipron outperformed oral semaglutide in reducing blood sugar and body weight over 52 ...

In contrast, one research trial using GLP-1 drugs on obese research subjects did not show a benefit from GLP-1 in the ...

Starting Wednesday, millions of Medicare-qualifying adults will have access to popular medications for weight loss at deep ...

The new report looked at how quickly you gain weight, and has explained why ...

July 8, 2026 expert reaction to review of obesity drugs and quality of life / heart health . A review published in The BMJ looks at obesity drugs and quality of life and heart hea ...

In Phase 3 trial in obesity/overweight in China, HRS-7535 achieved a mean weight loss of up to 10.9% at Week 44 and a mean weight loss of up to ...

Eli Lilly Canada announced today that Mounjaro® (tirzepatide), the first and only Health Canada-authorized once-weekly glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 ...

Polyendocrine metabolic ovarian syndrome (PMOS) – formerly known as PCOS – affects up to 20pc of women, with risks from type ...

WHEN ERIC STALLARD, an actuary and academic, began looking into the incidence of dementia among elderly Americans, he was so ...

W HEN ERIC STALLARD, an actuary and academic, began looking into the incidence of dementia among elderly Americans, he was so ...

With the right information and support, women living with PMOS, formerly known as PCOS, can manage their condition and lead healthy lives. AT A GLANCE: Polyendocrine metabolic syndrome (PMOS) is a ...

If you have type 2 diabetes, your health care provider may recommend metformin or Mounjaro to help manage your blood sugar.